Semustine
Top View
- Marrakesh Agreement Establishing the World Trade Organization
- Minimal Residual Disease Prior to Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia: a Meta-Analysis
- Pharmaceutical Compositions and Dosage Forms of Thalidomide
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- United States Patent $835 a 88: As: Inhibitor 1-((R)-3-(4-Amino-3-(4
- LEADING ARTICLE Causality of Myelodysplasia and Acute Myeloid
- Table 1. Database for Drugs Analyzed in This Study. Mechanism Mean Average # Mechanism Mean Average # of Action* Drug† NSC No
- Modified Bucy Is an Alternative Conditioning Regimen for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation
- Adjuvant Therapy in Resectable Gastric Cancer
- Efficacy of Allogeneic and Autologous Hematopoietic SCT in Patients With
- Secondary Cancers: Who Is at Risk?
- FDA-Approved Drug Screening for Compounds That Facilitate Hematopoietic Stem and Progenitor Cells (Hspcs) Expansion in Zebrafish
- Cytostatics in the Aquatic Environment: Analysis, Occurrence, and Possibilities for Removal
- Systemic Enzyme Therapy in Oncology Effect and Mode of Action
- Molecular Blueprints for Antitumor Drugs
- Review of Medicines for the Treatment of Common Tumours in Children
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Templated Nanoconjugates Joshua Cutler, Weston Daniel, David Giljohann, Chad Mirkin, Ke Zhang, Dan Zheng Issue Date